Article Versions Notes

Natoni A, Coyne MRE, Jacobsen A, Rainey MD, O'Brien G, Healy S, Montagnoli A, Moll J, O'Dwyer M, Santocanale C. Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models. Cancers. 2013; 5(3):901-918. https://doi.org/10.3390/cancers5030901

Natoni, Alessandro, Mark R. E. Coyne, Alan Jacobsen, Michael D. Rainey, Gemma O'Brien, Sandra Healy, Alessia Montagnoli, Jürgen Moll, Michael O'Dwyer, and Corrado Santocanale. 2013. "Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models" Cancers 5, no. 3: 901-918. https://doi.org/10.3390/cancers5030901

Natoni, A., Coyne, M. R. E., Jacobsen, A., Rainey, M. D., O'Brien, G., Healy, S., Montagnoli, A., Moll, J., O'Dwyer, M., & Santocanale, C. (2013). Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models. Cancers, 5(3), 901-918. https://doi.org/10.3390/cancers5030901